New Enterprise Associates 16, L.P.

CIK: 0001694560

Transaction Breakdown

Open Market Buys (P)2 (22.2%)

High conviction signal

Open Market Sales (S)1 (11.1%)

Position reduction

Option Exercises (M)1 (11.1%)

Derivative conversions

Awards (A)1 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)4 (44.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

TRVI

Trevi Therapeutics, Inc.

10% Owner

NEUE

NeueHealth, Inc.

10% Owner

MRKR

Marker Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (9 total)

NEUE
NeueHealth, Inc.
Oct 2, 2025
Award(A)
Warrant (Right to Buy)
Direct
372.3K shares-
NEUE
NeueHealth, Inc.
Oct 2, 2025
Exercise(M)
Direct
372.3K shares at avg. $0.01$4K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Tax Payment(F)
Direct
551 shares at avg. $6.75$4K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Disposition(D)
Direct
1.2M shares-
NEUE
NeueHealth, Inc.
Oct 2, 2025
In-the-Money(X)
Direct
189.2K shares at avg. $0.01$2K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Sale(S)
Direct
280 shares at avg. $6.75$2K
TRVI
Trevi Therapeutics, Inc.
Apr 17, 2025
In-the-Money(X)
Direct
1.9M shares at avg. $1.37$2.5M
MRKR
Marker Therapeutics, Inc.
Dec 23, 2024
Purchase(P)
Direct
554.3K shares at avg. $3.20$1.8M
NEUE
NeueHealth, Inc.
Oct 1, 2024
Purchase(P)
Warrant (Right to Buy)
Direct
61.9K shares-

		Type	Shares	Price		Ownership
Oct 2, 2025	NEUE NeueHealth, Inc.	Award(A) Warrant (Right to Buy)	372,255	-	-	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Exercise(M)	372,255	$0.01	$3,723	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Tax Payment(F)	551	$6.75	$3,719	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Disposition(D)	1,159,683	-	-	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	In-the-Money(X)	189,195	$0.01	$1,892	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Sale(S)	280	$6.75	$1,890	Direct
Apr 17, 2025	TRVI Trevi Therapeutics, Inc.	In-the-Money(X)	1,851,852	$1.37	$2,537,037	Direct
Dec 23, 2024	MRKR Marker Therapeutics, Inc.	Purchase(P)	554,250	$3.20	$1,773,600	Direct
Oct 1, 2024	NEUE NeueHealth, Inc.	Purchase(P) Warrant (Right to Buy)	61,865	-	-	Direct

1-9 of 9 transactions

About New Enterprise Associates 16, L.P.

New Enterprise Associates 16, L.P. (SEC CIK 0001694560) files insider reports with the SEC as 10% Owner of Trevi Therapeutics, Inc. (TRVI), 10% Owner of NeueHealth, Inc. (NEUE) and 10% Owner of Marker Therapeutics, Inc. (MRKR).

Signal8 holds 4 ownership filings by New Enterprise Associates 16, L.P. (3 Form 4, 1 Form 5), filed between Oct 3, 2024 and Feb 13, 2026. Those filings report 9 transactions, from Oct 1, 2024 to Oct 2, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on New Enterprise Associates 16, L.P.'s filings is in TIMONIUM, MD.

Recent filings by New Enterprise Associates 16, L.P.

Oct 2, 2025: Grant or award of NEUE derivative securities (Form 4, code A).
Oct 2, 2025: Option exercise of NEUE shares (Form 4, code M).
Oct 2, 2025: Tax withholding of NEUE shares (Form 4, code F).
Oct 2, 2025: Disposition to issuer transaction of NEUE shares (Form 4, code D).
Oct 2, 2025: Option exercise of NEUE shares (Form 4, code X).

Other insiders filing for Trevi Therapeutics, Inc. (TRVI)

Heffernan Michael Thomas, Director
Mathers Edward T, Director
Colangelo Dominick, Director
Meeker David P, Director
VANLENT ANNE, Director
Cassella James V, Chief Development Officer

How to read Form 4 transaction codes